The Longevity Science Foundation (LSF) has announced an extension of its "Invested in Her" campaign until October 1, 2026, with a goal to raise $250,000 for research into ovarian aging and menopause. This initiative is crucial as women, who generally live longer than men, often experience more years of poor health due to the biological challenges associated with menopause, which remains one of the most underfunded areas in health research. Currently, only 8.8% of National Institutes of Health (NIH) funding is allocated to women's health, with even less focusing specifically on ovarian aging and menopause.

This research gap has significant implications for women's long-term health. The hormonal changes that accompany menopause can affect various bodily systems, including heart health, brain function, and bone strength. By closing this research gap, the LSF aims to improve prevention, early intervention, and treatment options for women facing these challenges. The foundation is focusing on three key areas: better measurement of ovarian aging, understanding the biological mechanisms behind it, and developing early-stage interventions that treat reproductive aging as something that can be modified.

The campaign recently hosted an event in New York City, bringing together a diverse group of stakeholders, including investors, healthcare professionals, and advocates, to discuss the barriers to progress in women's health. Feedback from attendees highlighted the urgent need for more research funding and systemic changes to address these issues. With 100% of donations going directly to research, the LSF invites individuals to support this critical initiative to advance women's health and improve the quality of life for women everywhere.